SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Tumor Profiling Market Size & Growth ...
Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...
OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration with Gustave Roussy, the first European cancer center, to ...
Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...
Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...
One in six patients in phase II oncology clinical trials received a treatment that was eventually approved by the FDA, ...
Using preoperative chest CT scans, researchers identified novel preoperative biomarkers for lung cancer recurrence ...
News Medical on MSN1d
Early lung cancer diagnosis improved with ctDNA methylation biomarkersEarly diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...
News Medical on MSN2d
High GATA6 expression predicts improved outcomes in pancreatic cancerThis new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma ...
The Providence Cancer Center at Alaska Medical Center in Anchorage, part of Renton, Wash.-based Providence, will become the first hospital in Alaska to offer the targeted prostate cancer therapy, ...
“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback